Hypercholesterolemia News and Research

RSS
Hypercholesterolemia is a condition characterized by very high levels of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). The body needs this substance to build cell membranes, make certain hormones, and produce compounds that aid in fat digestion. Too much cholesterol, however, increases a person's risk of developing heart disease.

People with hypercholesterolemia have a high risk of developing a form of heart disease called coronary artery disease. This condition occurs when excess cholesterol in the bloodstream is deposited in the walls of blood vessels, particularly in the arteries that supply blood to the heart (coronary arteries). The abnormal buildup of cholesterol forms clumps (plaque) that narrow and harden artery walls. As the clumps get bigger, they can clog the arteries and restrict the flow of blood to the heart. The buildup of plaque in coronary arteries causes a form of chest pain called angina and greatly increases a person's risk of having a heart attack.

Inherited forms of hypercholesterolemia can also cause health problems related to the buildup of excess cholesterol in other tissues. If cholesterol accumulates in tendons, it causes characteristic growths called tendon xanthomas. These growths most often affect the Achilles tendons and tendons in the hands and fingers. Yellowish cholesterol deposits under the skin of the eyelids are known as xanthelasmata. Cholesterol can also accumulate at the edges of the clear, front surface of the eye (the cornea), leading to a gray-colored ring called an arcus cornealis.
Lomitapide shows promise in treating homozygous familial hypercholesterolemia

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

University of Cambridge forms new spin-out company to supply hIPSC-derived cells

University of Cambridge forms new spin-out company to supply hIPSC-derived cells

High blood cholesterol far more common than previously recognized

High blood cholesterol far more common than previously recognized

Smoke-free laws lead to fewer heart attacks

Smoke-free laws lead to fewer heart attacks

Men with cardiovascular risk factors more likely to develop peripheral artery disease

Men with cardiovascular risk factors more likely to develop peripheral artery disease

Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

CKD may thicken carotid arteries, raise CVD risk in children

CKD may thicken carotid arteries, raise CVD risk in children

U.S. District Court rules in favor of Alnylam in patent infringement case against Tekmira

U.S. District Court rules in favor of Alnylam in patent infringement case against Tekmira

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Global platelet reactivity effectively identifies ACS patients at high risk of ischemic events

Global platelet reactivity effectively identifies ACS patients at high risk of ischemic events

Mexican-Americans with ancestral links have higher insulin resistance levels

Mexican-Americans with ancestral links have higher insulin resistance levels

New results describe development of DC cancer vaccine with enhanced immunogenic potential

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Smoking poses less risk for dyslipidemia in very elderly

Smoking poses less risk for dyslipidemia in very elderly

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Hard work puts stress on the female heart

Hard work puts stress on the female heart

Regeneron reports total revenues of $304 million for second quarter 2012

Regeneron reports total revenues of $304 million for second quarter 2012

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

Regeneron, Sanofi initiate enrollment in SAR236553/REGN727 Phase 3 program

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.